| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.47e-04 | 231 | 69 | 6 | GO:0005085 | |
| GeneOntologyCellularComponent | cation channel complex | 1.47e-04 | 235 | 71 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 2.61e-04 | 91 | 71 | 4 | GO:0008076 | |
| GeneOntologyCellularComponent | potassium channel complex | 4.35e-04 | 104 | 71 | 4 | GO:0034705 | |
| Domain | ARM-type_fold | 3.46e-05 | 339 | 69 | 8 | IPR016024 | |
| Domain | ARM-like | 4.83e-04 | 270 | 69 | 6 | IPR011989 | |
| Domain | LRR_1 | 1.29e-03 | 219 | 69 | 5 | PF00560 | |
| Domain | Spectrin | 3.24e-03 | 23 | 69 | 2 | PF00435 | |
| Domain | Leu-rich_rpt | 3.27e-03 | 271 | 69 | 5 | IPR001611 | |
| Domain | LRR_8 | 3.69e-03 | 171 | 69 | 4 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 4.17e-03 | 177 | 69 | 4 | IPR003591 | |
| Domain | LRR_TYP | 4.17e-03 | 177 | 69 | 4 | SM00369 | |
| Domain | HECT | 4.45e-03 | 27 | 69 | 2 | PF00632 | |
| Domain | HECTc | 4.45e-03 | 27 | 69 | 2 | SM00119 | |
| Domain | HECT_dom | 4.45e-03 | 27 | 69 | 2 | IPR000569 | |
| Domain | HECT | 4.45e-03 | 27 | 69 | 2 | PS50237 | |
| Domain | LisH | 4.78e-03 | 28 | 69 | 2 | SM00667 | |
| Domain | LisH | 4.78e-03 | 28 | 69 | 2 | IPR006594 | |
| Domain | LISH | 4.78e-03 | 28 | 69 | 2 | PS50896 | |
| Domain | Spectrin_repeat | 5.12e-03 | 29 | 69 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 6.21e-03 | 32 | 69 | 2 | IPR018159 | |
| Domain | SPEC | 6.21e-03 | 32 | 69 | 2 | SM00150 | |
| Domain | LRR | 6.53e-03 | 201 | 69 | 4 | PS51450 | |
| Domain | VG_K_chnl | 6.60e-03 | 33 | 69 | 2 | IPR028325 | |
| Domain | - | 6.66e-03 | 321 | 69 | 5 | 3.80.10.10 | |
| Domain | L_dom-like | 7.28e-03 | 328 | 69 | 5 | IPR032675 | |
| Domain | Serpin_dom | 7.81e-03 | 36 | 69 | 2 | IPR023796 | |
| Domain | SERPIN | 8.24e-03 | 37 | 69 | 2 | SM00093 | |
| Domain | SERPIN | 8.24e-03 | 37 | 69 | 2 | PS00284 | |
| Domain | Ion_trans_dom | 8.66e-03 | 114 | 69 | 3 | IPR005821 | |
| Domain | Ion_trans | 8.66e-03 | 114 | 69 | 3 | PF00520 | |
| Domain | Serpin | 8.68e-03 | 38 | 69 | 2 | PF00079 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | THADA ASAP2 DNAJC13 KCNQ5 ABHD2 MACF1 G2E3 ZNF528 IQCN HUWE1 ECPAS MDM4 BCR SLC4A5 CEP43 DNAH14 | 6.16e-08 | 1489 | 73 | 16 | 28611215 |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 24821553 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 34900980 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 30886146 | ||
| Pubmed | Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage. | 1.30e-05 | 3 | 73 | 2 | 15788536 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 36672824 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 34485508 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 18172009 | ||
| Pubmed | REV7-p53 interaction inhibits ATM-mediated DNA damage signaling. | 1.30e-05 | 3 | 73 | 2 | 38557443 | |
| Pubmed | Molecular Pathway of Microtubule Organization at the Golgi Apparatus. | 1.30e-05 | 3 | 73 | 2 | 27666745 | |
| Pubmed | 1.54e-05 | 529 | 73 | 8 | 14621295 | ||
| Pubmed | PEA15 regulates the DNA damage-induced cell cycle checkpoint and oncogene-directed transformation. | 1.74e-05 | 24 | 73 | 3 | 24710276 | |
| Pubmed | CACNA1A RELCH KCNQ5 KALRN KCNF1 PDE4DIP KCNAB2 MACF1 HUWE1 SHOC2 BCR | 2.46e-05 | 1139 | 73 | 11 | 36417873 | |
| Pubmed | 2.50e-05 | 27 | 73 | 3 | 18685082 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 26711340 | ||
| Pubmed | ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation. | 2.60e-05 | 4 | 73 | 2 | 16082221 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 30783677 | ||
| Pubmed | HUWE1 is a molecular link controlling RAF-1 activity supported by the Shoc2 scaffold. | 2.60e-05 | 4 | 73 | 2 | 25022756 | |
| Pubmed | The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis. | 2.60e-05 | 4 | 73 | 2 | 22213803 | |
| Pubmed | HDMX folds the nascent p53 mRNA following activation by the ATM kinase. | 2.60e-05 | 4 | 73 | 2 | 24813712 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 3.03e-05 | 582 | 73 | 8 | 20467437 | |
| Pubmed | VGF CACNA1A DNAJC13 AKAP9 KALRN PDE4DIP KCNAB2 MACF1 HUWE1 BCR | 3.24e-05 | 963 | 73 | 10 | 28671696 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 3.26e-05 | 588 | 73 | 8 | 38580884 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 15929992 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 16442529 | ||
| Pubmed | 6.25e-05 | 101 | 73 | 4 | 9872452 | ||
| Pubmed | Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage. | 6.48e-05 | 6 | 73 | 2 | 16943424 | |
| Pubmed | The role of USP7 in the Shoc2-ERK1/2 signaling axis and Noonan-like syndrome with loose anagen hair. | 6.48e-05 | 6 | 73 | 2 | 34553755 | |
| Pubmed | ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. | 6.48e-05 | 6 | 73 | 2 | 16163388 | |
| Pubmed | 8.01e-05 | 493 | 73 | 7 | 15368895 | ||
| Pubmed | 8.05e-05 | 209 | 73 | 5 | 36779422 | ||
| Pubmed | 8.43e-05 | 497 | 73 | 7 | 23414517 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 26519477 | ||
| Pubmed | 1.10e-04 | 1116 | 73 | 10 | 31753913 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.55e-04 | 736 | 73 | 8 | 29676528 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 1.83e-04 | 754 | 73 | 8 | 33060197 | |
| Pubmed | 1.93e-04 | 10 | 73 | 2 | 17478428 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 2.15e-04 | 139 | 73 | 4 | 16985003 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.18e-04 | 774 | 73 | 8 | 15302935 | |
| Pubmed | 2.94e-04 | 151 | 73 | 4 | 17043677 | ||
| Pubmed | 3.34e-04 | 13 | 73 | 2 | 20164180 | ||
| Pubmed | VPS9D1 KALRN LRSAM1 PDE4DIP KCNAB2 FMN2 MACF1 ZNF528 ATM HUWE1 | 3.43e-04 | 1285 | 73 | 10 | 35914814 | |
| Pubmed | Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates. | 3.69e-04 | 66 | 73 | 3 | 24811749 | |
| Pubmed | Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients. | 3.89e-04 | 14 | 73 | 2 | 28878358 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | RELCH DENND4A THADA ASAP2 DNAJC13 RNH1 SHOC2 BCR CEP43 LRRC47 | 4.26e-04 | 1321 | 73 | 10 | 27173435 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 4.30e-04 | 857 | 73 | 8 | 25609649 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 4.44e-04 | 861 | 73 | 8 | 36931259 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 4.94e-04 | 475 | 73 | 6 | 31040226 | |
| Pubmed | Unpackaging the genetics of mammalian fertility: strategies to identify the "reproductive genome". | 5.12e-04 | 16 | 73 | 2 | 29878059 | |
| Pubmed | 5.59e-04 | 76 | 73 | 3 | 27542412 | ||
| Pubmed | 6.67e-04 | 503 | 73 | 6 | 36217030 | ||
| Pubmed | 8.06e-04 | 20 | 73 | 2 | 20075150 | ||
| Pubmed | 8.89e-04 | 21 | 73 | 2 | 15014966 | ||
| Pubmed | 8.89e-04 | 21 | 73 | 2 | 25590999 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 8.95e-04 | 203 | 73 | 4 | 22083510 | |
| Pubmed | 9.77e-04 | 22 | 73 | 2 | 31837246 | ||
| Pubmed | 9.77e-04 | 22 | 73 | 2 | 19794065 | ||
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 1.03e-03 | 211 | 73 | 4 | 17314511 | |
| Pubmed | 1.07e-03 | 23 | 73 | 2 | 22792062 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 1.17e-03 | 218 | 73 | 4 | 33378226 | |
| Pubmed | 1.31e-03 | 102 | 73 | 3 | 11214970 | ||
| Pubmed | 1.35e-03 | 103 | 73 | 3 | 10819331 | ||
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | 1.42e-03 | 1031 | 73 | 8 | 16710414 | |
| Pubmed | 1.47e-03 | 27 | 73 | 2 | 19026994 | ||
| Pubmed | 1.49e-03 | 233 | 73 | 4 | 37704626 | ||
| Pubmed | 1.59e-03 | 1049 | 73 | 8 | 27880917 | ||
| Pubmed | Identification of Arx transcriptional targets in the developing basal forebrain. | 1.59e-03 | 28 | 73 | 2 | 18799476 | |
| Pubmed | 1.70e-03 | 29 | 73 | 2 | 18239623 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 1.70e-03 | 1061 | 73 | 8 | 33845483 | |
| Pubmed | 1.76e-03 | 608 | 73 | 6 | 16713569 | ||
| Pubmed | A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. | 1.90e-03 | 419 | 73 | 5 | 28700943 | |
| Pubmed | 1.95e-03 | 1084 | 73 | 8 | 11544199 | ||
| Pubmed | 1.97e-03 | 622 | 73 | 6 | 14574404 | ||
| Pubmed | 1.99e-03 | 118 | 73 | 3 | 21078624 | ||
| Pubmed | 1.99e-03 | 118 | 73 | 3 | 26264872 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 2.09e-03 | 120 | 73 | 3 | 31413325 | |
| Cytoband | 14q32.13 | 3.34e-04 | 17 | 73 | 2 | 14q32.13 | |
| Cytoband | 2p25 | 3.75e-04 | 18 | 73 | 2 | 2p25 | |
| Cytoband | 3q21.2 | 5.14e-04 | 21 | 73 | 2 | 3q21.2 | |
| Cytoband | 19p13 | 8.53e-04 | 27 | 73 | 2 | 19p13 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-07 | 193 | 73 | 6 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-07 | 193 | 73 | 6 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-07 | 193 | 73 | 6 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-07 | 195 | 73 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-07 | 195 | 73 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.40e-06 | 159 | 73 | 5 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.37e-05 | 186 | 73 | 5 | 927723ad579bbd9947ff525bd501e222d3fa9289 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 186 | 73 | 5 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.63e-05 | 193 | 73 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.68e-05 | 194 | 73 | 5 | b111d10c99d7ff7eb261cd7786cd9d9a549049b1 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-05 | 194 | 73 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.72e-05 | 195 | 73 | 5 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.72e-05 | 195 | 73 | 5 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 195 | 73 | 5 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.85e-05 | 198 | 73 | 5 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-05 | 198 | 73 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-05 | 198 | 73 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-05 | 198 | 73 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.85e-05 | 198 | 73 | 5 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.89e-05 | 199 | 73 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.94e-05 | 200 | 73 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-04 | 150 | 73 | 4 | 4f31867cb85253ff6d22f3b02ef972a42cb41123 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 159 | 73 | 4 | d3f81ba22160568ccaa6d2b04ebfd30630f9a6db | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 165 | 73 | 4 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 165 | 73 | 4 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.67e-04 | 168 | 73 | 4 | 5e721268f0baa51d3f640f7f4c41db769ebef210 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.79e-04 | 171 | 73 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-04 | 174 | 73 | 4 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.91e-04 | 174 | 73 | 4 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 178 | 73 | 4 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.17e-04 | 180 | 73 | 4 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 2.27e-04 | 182 | 73 | 4 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 183 | 73 | 4 | bf7f1cb55ed55981b8b355d5774055c96e658ff2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 183 | 73 | 4 | 9533db4db2c6ae78d7ca1682cf4efed12183396f | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 2.36e-04 | 184 | 73 | 4 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.36e-04 | 184 | 73 | 4 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 185 | 73 | 4 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.46e-04 | 186 | 73 | 4 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-04 | 187 | 73 | 4 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 187 | 73 | 4 | b51af2824e65734f333b1325117f4a2e88b17c23 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 187 | 73 | 4 | 3ca3954f45f167e98a230f2847f0582d74fcd32e | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.51e-04 | 187 | 73 | 4 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-04 | 187 | 73 | 4 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-04 | 188 | 73 | 4 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.62e-04 | 189 | 73 | 4 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.67e-04 | 190 | 73 | 4 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-04 | 190 | 73 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-04 | 192 | 73 | 4 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-04 | 192 | 73 | 4 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-04 | 193 | 73 | 4 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 2.83e-04 | 193 | 73 | 4 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-04 | 193 | 73 | 4 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-04 | 193 | 73 | 4 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-04 | 193 | 73 | 4 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-04 | 193 | 73 | 4 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-04 | 193 | 73 | 4 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-04 | 193 | 73 | 4 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-04 | 194 | 73 | 4 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | COVID-19-lung-NK_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.89e-04 | 194 | 73 | 4 | 4c92f18e0a34fb50630d4b260eaf179202508b6d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-04 | 194 | 73 | 4 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-04 | 194 | 73 | 4 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-04 | 194 | 73 | 4 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-04 | 194 | 73 | 4 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-04 | 196 | 73 | 4 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.06e-04 | 197 | 73 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 3.12e-04 | 198 | 73 | 4 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 198 | 73 | 4 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 198 | 73 | 4 | 31ba87552be97c9b78c9e82f98e96699ccb19824 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.12e-04 | 198 | 73 | 4 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 198 | 73 | 4 | fa84bf8533d1b91d2c2bcf06b710670605072b89 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 198 | 73 | 4 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 3.24e-04 | 200 | 73 | 4 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 3.24e-04 | 200 | 73 | 4 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.24e-04 | 200 | 73 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.24e-04 | 200 | 73 | 4 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 3.24e-04 | 200 | 73 | 4 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.24e-04 | 200 | 73 | 4 | d2422aaf807010194994db97142b9fd2e807312d | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.24e-04 | 200 | 73 | 4 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.24e-04 | 200 | 73 | 4 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.24e-04 | 200 | 73 | 4 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.24e-04 | 200 | 73 | 4 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 3.24e-04 | 200 | 73 | 4 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.24e-04 | 200 | 73 | 4 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.24e-04 | 200 | 73 | 4 | bfbd2ccf4b28901aad63d70a382a8247e4458ba6 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.24e-04 | 200 | 73 | 4 | 1d2ee63010b7b8b38bea7d3b30eebfbcdd18b967 | |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; PC3; HT_HG-U133A | 2.89e-06 | 196 | 72 | 7 | 6638_DN | |
| Disease | anxiety disorder, environmental factor | 5.55e-06 | 2 | 70 | 2 | EFO_0000469, EFO_0006788 | |
| Disease | serpin A9 measurement | 3.32e-05 | 4 | 70 | 2 | EFO_0802062 | |
| Disease | infertility (implicated_via_orthology) | 1.16e-04 | 7 | 70 | 2 | DOID:5223 (implicated_via_orthology) | |
| Disease | kallistatin measurement | 1.54e-04 | 8 | 70 | 2 | EFO_0008196 | |
| Disease | triple-negative breast cancer | 2.47e-04 | 10 | 70 | 2 | EFO_0005537 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.31e-04 | 148 | 70 | 4 | C0279702 | |
| Disease | serum albumin measurement | 5.08e-04 | 592 | 70 | 7 | EFO_0004535 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 5.71e-04 | 15 | 70 | 2 | C0496930 | |
| Disease | hepcidin:transferrin saturation ratio | 5.71e-04 | 15 | 70 | 2 | EFO_0007902 | |
| Disease | Benign neoplasm of bladder | 5.71e-04 | 15 | 70 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 5.71e-04 | 15 | 70 | 2 | C0154091 | |
| Disease | neutrophil percentage of leukocytes | 6.06e-04 | 610 | 70 | 7 | EFO_0007990 | |
| Disease | Carcinoma of bladder | 8.28e-04 | 18 | 70 | 2 | C0699885 | |
| Disease | Malignant neoplasm of breast | 9.61e-04 | 1074 | 70 | 9 | C0006142 | |
| Disease | Dystonia | 1.14e-03 | 86 | 70 | 3 | C0013421 | |
| Disease | Sarcosine measurement | 1.36e-03 | 23 | 70 | 2 | EFO_0021668 | |
| Disease | response to norepinephrine-dopamine reuptake inhibitor | 1.74e-03 | 26 | 70 | 2 | EFO_0007870 | |
| Disease | alpha fetoprotein measurement | 1.75e-03 | 100 | 70 | 3 | EFO_0010583 | |
| Disease | coronary artery disease (is_implicated_in) | 1.75e-03 | 100 | 70 | 3 | DOID:3393 (is_implicated_in) | |
| Disease | eosinophil percentage of leukocytes | 1.94e-03 | 746 | 70 | 7 | EFO_0007991 | |
| Disease | cerebral infarction (is_implicated_in) | 2.16e-03 | 29 | 70 | 2 | DOID:3526 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KTLDLLVTPHKSTDL | 1936 | O00555 | |
| ILDHLPSVTKESSLR | 1071 | Q99996 | |
| THPVDLSSLSSKLLP | 351 | Q9H8M2 | |
| TRSTLVLHDLLKHTP | 651 | P11274 | |
| EVTSLKHLLETSTLP | 671 | Q6ULP2 | |
| PLVHESLLTIPKSLS | 346 | P08910 | |
| LPSSSDLDLLHKIVL | 201 | Q8IVW4 | |
| IPLSETSSTKLSHID | 86 | P23109 | |
| LPCLLHLLSSPKESI | 341 | O15131 | |
| HKILIHSLRPSVLTS | 416 | Q7Z401 | |
| LPTELTKTPSLAHLD | 696 | Q9H0B3 | |
| IKTLPSHLCTSALLS | 991 | O94822 | |
| TLLSLSHAPLDSLKA | 936 | Q9P260 | |
| KHLSPSSVLADLVTT | 8656 | Q8WXI7 | |
| LTLTPSLLTLDTLTH | 26 | Q8WY50 | |
| DIVVSPSTKLLSLAH | 1766 | M0R2J8 | |
| LLILLTVGSDSHLSL | 56 | Q8NGN2 | |
| TLIILLSALDPKLHS | 41 | O95918 | |
| LDPLVTKTHLLSLSS | 1406 | Q14667 | |
| PLLSISSDSLLSHVE | 106 | Q9UI95 | |
| SKALEKTLLSSSHPL | 31 | A2A368 | |
| KLTHSLSTSDITAIP | 336 | O15151 | |
| HLTSLLPKSCSLLSL | 66 | Q6UWE0 | |
| PDIAHLASLKTLDLS | 196 | Q8N1G4 | |
| LKPSIETLSTDLHTI | 241 | O43150 | |
| LILSVFSTIPEHTKL | 141 | Q9NR82 | |
| TKLHLVESLLSRIPS | 836 | Q5VYK3 | |
| QTLHPISSEELLSLK | 186 | P14921 | |
| LGSVSLKHSLSLLDL | 191 | P56589 | |
| HLSPDSTKALLELTE | 311 | Q8TDF6 | |
| SLVPKITSLLDKLHS | 276 | O60229 | |
| SLILLSIDLTSPHVK | 266 | Q9NRD0 | |
| LEPSHSLLSTEAKLV | 356 | P20823 | |
| TTLPATLSIALHKST | 166 | Q9UQV4 | |
| VTHELASSLDLLPTL | 326 | P15289 | |
| ILPSTRASVHLLKST | 691 | Q9ULI3 | |
| PLSSSKTITLHILDV | 431 | Q9Y5G1 | |
| LTSIVHLERTPKLSS | 331 | Q7Z6Z7 | |
| PKLSSSIIHEIDSIL | 341 | Q13303 | |
| STLTTTHLKAEPLTK | 541 | Q9UPN3 | |
| KLLHHLSDLALTLPT | 81 | Q86U44 | |
| TPLLKLSCSDTHLSE | 181 | Q96R84 | |
| STHSLPLLLFILSSI | 106 | Q8TEZ7 | |
| SAKILSELFTVHTLP | 591 | Q7L622 | |
| IDSSTLEPTKSLHLH | 931 | Q13315 | |
| IISAAETLTLHPSSK | 481 | Q9UBT7 | |
| VSLSEPKSKSSLHLL | 206 | O95684 | |
| LSSLLALLHSLPSSR | 1816 | O75165 | |
| THLEPFSLLCKSLLS | 2896 | Q0VDD8 | |
| HHSSKTISSLSPVLL | 36 | Q8NFN8 | |
| SSLSHILSIKEFPLL | 3686 | Q8NDH2 | |
| AHSLLTKTPDLSLSA | 111 | Q9NZ56 | |
| SLPLSSLTHVLRSLT | 471 | Q13416 | |
| SEKIPHLISSVLLRS | 266 | Q6YHU6 | |
| TIDSLIELSTKLHLP | 451 | O15240 | |
| PSISHLLKITLSARD | 11 | A6NCI5 | |
| SIHILPSSIKELTQL | 111 | Q9UQ13 | |
| HLVHSLTVPSKDLTL | 116 | Q86WD7 | |
| LSTTHLEKSSVLPIA | 146 | Q15399 | |
| PSTVLRHFLEKLTIS | 1886 | Q8N2C7 | |
| SLLHTLALPSPKLEL | 121 | Q86U17 | |
| SSTLRTLPTLQELHL | 106 | P13489 | |
| KPHVSTLSLHSLFEL | 151 | Q9BY07 | |
| AVSLLLPSLTLLVSH | 66 | Q9P283 | |
| KHLLHVTSRPLLATT | 146 | Q9BYW2 | |
| KSSTLILPHATLRDT | 86 | A0A087WT03 | |
| SPLEKISSSVKSHLL | 146 | Q3MIS6 | |
| LSLVTSLVSHLLSLP | 266 | Q9Y2B5 | |
| KLHPSSSLCLALTLL | 361 | A5PLN9 | |
| LSSCHLTHLILLPKS | 516 | Q6ZQQ6 | |
| LTIAATEPVTLLHSK | 126 | Q13487 | |
| LKVTEDPALILHLTS | 676 | O94874 | |
| SRLKLSHSDTFIPLL | 466 | Q9H3M0 | |
| NSKLTPELLVHLTST | 1131 | Q5VU43 |